Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Beaumont

Showing results (21-30 of 368) with videos related to

Pageof 37
Sort By:
Immunobiology|December 1, 1980
Purification of a monoclonal IgA with antiheparin activityE Szondy, J L Beaumont
Atherosclerosis|December 1, 1990
Retinyl palmitate labeled intestinally derived lipoproteins accumulate in the circulation of WHHL rabbitsJ L Beaumont, F Assadollahi
La Nouvelle Presse Medicale|February 21, 1981
[Vascular thrombosis in synthetic estrogen-progestogen users: an immune mechanism (author's transl)]V Beaumont, J L Beaumont
Therapeutische Umschau. Revue Therapeutique|February 1, 1982
[Vascular thrombosis related to oral contraceptives and antiethinylestradiol antibodies--epidemiology and prevention (author's transl)]V Beaumont, J L Beaumont
La Revue Du Praticien|February 1, 1979
[Atheromatous lesions. Description of lesions and pathogenic mechanisms]B Jacotot, J L Beaumont
Pathologie-Biologie|April 1, 1972
[Agglutination phenomenon of lipid particles. Its value in sero-immunology]J L Beaumont, L Lorenzelli
Atherosclerosis|May 1, 1973
[Serum lipoproteins and antilipemic drugs related to clofibrate. Their in vitro interaction]J L Beaumont, C Dachet
Bibliotheca Nutritio Et Dieta|January 1, 1977
[Dietary fats, lipidemia and blood coagulation]B Jacotot, J L Beaumont
Atherosclerosis|June 1, 1990
Circulating IgA-Lp complexes in Watanabe heritable hyperlipidemic and cholesterol fed NZW rabbitsJ L Beaumont, P Vivier
Presse Medicale (Paris, France : 1983)|June 17, 1989
[Vascular risk of oral contraceptive agents: realities and mechanisms. I. Risk evaluation]V Beaumont, J L Beaumont
Pageof 37

Showing results (21-30 of 368) with videos related to

Sort By:
Pageof 37
Immunobiology|December 1, 1980
Purification of a monoclonal IgA with antiheparin activityE Szondy, J L Beaumont
Atherosclerosis|December 1, 1990
Retinyl palmitate labeled intestinally derived lipoproteins accumulate in the circulation of WHHL rabbitsJ L Beaumont, F Assadollahi
La Nouvelle Presse Medicale|February 21, 1981
[Vascular thrombosis in synthetic estrogen-progestogen users: an immune mechanism (author's transl)]V Beaumont, J L Beaumont
Therapeutische Umschau. Revue Therapeutique|February 1, 1982
[Vascular thrombosis related to oral contraceptives and antiethinylestradiol antibodies--epidemiology and prevention (author's transl)]V Beaumont, J L Beaumont
La Revue Du Praticien|February 1, 1979
[Atheromatous lesions. Description of lesions and pathogenic mechanisms]B Jacotot, J L Beaumont
Pathologie-Biologie|April 1, 1972
[Agglutination phenomenon of lipid particles. Its value in sero-immunology]J L Beaumont, L Lorenzelli
Atherosclerosis|May 1, 1973
[Serum lipoproteins and antilipemic drugs related to clofibrate. Their in vitro interaction]J L Beaumont, C Dachet
Bibliotheca Nutritio Et Dieta|January 1, 1977
[Dietary fats, lipidemia and blood coagulation]B Jacotot, J L Beaumont
Atherosclerosis|June 1, 1990
Circulating IgA-Lp complexes in Watanabe heritable hyperlipidemic and cholesterol fed NZW rabbitsJ L Beaumont, P Vivier
Presse Medicale (Paris, France : 1983)|June 17, 1989
[Vascular risk of oral contraceptive agents: realities and mechanisms. I. Risk evaluation]V Beaumont, J L Beaumont
Pageof 37